Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.

@article{Gavaza2012PharmacistRO,
  title={Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.},
  author={Paul Gavaza and Carolyn M. Brown and Kenneth A. Lawson and Karen Rascati and Mary A. Steinhardt and James T. Wilson},
  journal={Journal of the American Pharmacists Association : JAPhA},
  year={2012},
  volume={52 5},
  pages={e109-12}
}
OBJECTIVE To identify barriers to and facilitators of pharmacist reporting of serious adverse drug events (ADEs) to the Food and Drug Administration (FDA). METHOD Two focus groups consisting of practicing pharmacists were held in Austin, TX, in 2009. The following open-ended questions were used in the focus groups: (1) What do you think would make it easier to report serious ADEs to the FDA? (2) What do you think would make it more difficult to report serious ADEs to the FDA? A content… CONTINUE READING